ES433226A1 - Un procedimiento para la preparación de compuestos antibióticos de cefalosporina. - Google Patents

Un procedimiento para la preparación de compuestos antibióticos de cefalosporina.

Info

Publication number
ES433226A1
ES433226A1 ES433226A ES433226A ES433226A1 ES 433226 A1 ES433226 A1 ES 433226A1 ES 433226 A ES433226 A ES 433226A ES 433226 A ES433226 A ES 433226A ES 433226 A1 ES433226 A1 ES 433226A1
Authority
ES
Spain
Prior art keywords
compound
formula
group
isomer
carbon atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES433226A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB59517/73A external-priority patent/GB1496757A/en
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of ES433226A1 publication Critical patent/ES433226A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES433226A 1973-12-21 1974-12-20 Un procedimiento para la preparación de compuestos antibióticos de cefalosporina. Expired ES433226A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB59517/73A GB1496757A (en) 1973-12-21 1973-12-21 Cephalosporin derivatives
GB4300574 1974-10-03

Publications (1)

Publication Number Publication Date
ES433226A1 true ES433226A1 (es) 1977-07-01

Family

ID=26265028

Family Applications (2)

Application Number Title Priority Date Filing Date
ES433226A Expired ES433226A1 (es) 1973-12-21 1974-12-20 Un procedimiento para la preparación de compuestos antibióticos de cefalosporina.
ES451604A Expired ES451604A1 (es) 1973-12-21 1976-09-16 Un procedimiento para la preparacion.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES451604A Expired ES451604A1 (es) 1973-12-21 1976-09-16 Un procedimiento para la preparacion.

Country Status (15)

Country Link
JP (1) JPS5844675B2 (da)
AT (1) AT344888B (da)
CH (1) CH617703A5 (da)
DE (1) DE2460537A1 (da)
DK (1) DK674674A (da)
ES (2) ES433226A1 (da)
FI (1) FI65258C (da)
FR (1) FR2255076B1 (da)
HU (1) HU172234B (da)
IE (1) IE42144B1 (da)
IL (1) IL46302A (da)
LU (1) LU71550A1 (da)
NL (1) NL7416665A (da)
NO (1) NO744621L (da)
SE (1) SE7416195L (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4095021A (en) 1973-12-21 1978-06-13 Glaxo Laboratories Limited 3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof
US4144392A (en) 1973-12-21 1979-03-13 Glaxo Laboratories Limited Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
GB1555471A (en) * 1975-06-19 1979-11-14 Glaxo Lab Ltd 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
US4165430A (en) 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
US4304770A (en) 1976-04-12 1981-12-08 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid
US4278670A (en) * 1976-07-12 1981-07-14 Smithkline Corporation 7-Alpha-oxyiminoacylcephalosporins
GB1591439A (en) 1976-10-01 1981-06-24 Glaxo Operations Ltd 7-syn (oxyimino -acylamido) cephalosporins
GB1596278A (en) 1976-11-30 1981-08-26 Glaxo Operations Ltd 7-(-oxyimino-acetamino)cephalosporin derivatives
PH17188A (en) 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
SE439312B (sv) * 1977-03-25 1985-06-10 Roussel Uclaf Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra
ES485441A1 (es) * 1978-10-27 1980-07-01 Glaxo Group Ltd Un procedimiento para la preparacion de antibioticos de ce- falosporina
FR2457296A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
FR2552432B2 (fr) * 1983-09-27 1985-10-25 Roussel Uclaf Nouvelles oximes derivees de l'acide 2-amino thiazol- 4-yl acetique, procede de preparation
US20040166434A1 (en) 2003-02-21 2004-08-26 Dammel Ralph R. Photoresist composition for deep ultraviolet lithography

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
GB1348984A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Antibiotics and processes for their production
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds

Also Published As

Publication number Publication date
CH617703A5 (en) 1980-06-13
JPS50105689A (da) 1975-08-20
FR2255076B1 (da) 1978-11-10
NL7416665A (nl) 1975-06-24
DE2460537A1 (de) 1975-07-03
FI371374A (da) 1975-06-22
ATA1020174A (de) 1977-12-15
NO744621L (da) 1975-07-21
DK674674A (da) 1975-09-08
SE7416195L (sv) 1975-09-22
HU172234B (hu) 1978-07-28
FR2255076A1 (da) 1975-07-18
FI65258C (fi) 1984-04-10
IE42144L (en) 1975-06-21
FI65258B (fi) 1983-12-30
LU71550A1 (da) 1976-04-13
ES451604A1 (es) 1977-12-16
IE42144B1 (en) 1980-06-18
IL46302A (en) 1978-09-29
AT344888B (de) 1978-08-10
IL46302A0 (en) 1975-03-13
AU7673574A (en) 1976-06-24
DE2460537C2 (da) 1987-01-22
JPS5844675B2 (ja) 1983-10-04

Similar Documents

Publication Publication Date Title
ES433226A1 (es) Un procedimiento para la preparación de compuestos antibióticos de cefalosporina.
ES427859A1 (es) Un procedimiento para la preparacion de compuestos de cefa-losporina.
ES402651A1 (es) Procedimiento para la preparacion de derivados de la cefa- losperina.
ES8101628A1 (es) Procedimiento para la estabilizacion de materias organicas polimeras.
GB1440216A (en) Derivatives of penam-3-carboxylic acid and cephem-4-carboxylic acid and processes for their manufacture
ES8507484A1 (es) Procedimiento de producir compuestos beta-lactamicos y similares
ES371709A1 (es) Un metodo para producir una penicilina sintetica.
GB1287786A (en) O-desacetyl-7-n-acylamino-cephalosporanic acids and process for their manufacture
KR850007604A (ko) 샤르트류신 유도체 또는 그 염의 제조방법
IE38821B1 (en) Thiophene derivatives process for their preparation and compositions incorporating them
KR890002174A (ko) 삼환성 세팜 화합물, 그의 제조방법 및 용도
FR2479219B1 (da)
US3464999A (en) Thiadiazolylisothiazoles
US4039534A (en) 4-Thio substituted-Δ2 -cephalosporin intermediates
US3162651A (en) Thienylalkyl esters of 3-sulphamyl-4-chlorobenzoic acid
ES436173A1 (es) Procedimiento para la preparacion de hidrazinocefalospori- nas.
GB1512044A (en) 1,3-dihydrocarbyl-pyrazole compounds and their use as ultra-violet stabilizers
ES461983A1 (es) Un procedimiento para la preparacion de nuevas cefalospori- nas.
Beyerman et al. On the synthesis of cephalosporin antibiotics. Synthesis of substituted furo‐oxathiins
MIZOKAMI et al. Synthesis of 2α-methyl-and 2β-methyl-3-(substituted methyl) cephalosporins, and 2, 3-diexomethylenecepham
JPS5283363A (en) Synthesis of novel isoindoline derivative pigment
ES383683A1 (es) Procedimiento para la preparacion de compuestos de cumarina.
US4012410A (en) 2-(4-Methoxyoxazolidinone-4-yl)thiazolidine t-butyl esters
GB1271013A (en) Novel cephalosporin derivatives, and processes for their preparation
ES395952A1 (es) Un metodo para la produccion de derivados de dihidropirimi-dopiridazina.